Lindbrook Capital, LLC Enanta Pharmaceuticals Inc Transaction History

Lindbrook Capital, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 25, 2023	SELL	$11.09 - $22.13 $765 - $1,526	-69 Reduced 75.82%	22 $0
Q2 2023 Jul 28, 2023	BUY	$20.68 - $39.85 $1,654 - $3,188	80 Added 727.27%	91 $1,000
Q1 2023 Apr 26, 2023	SELL	$38.82 - $54.59 $1,086 - $1,528	-28 Reduced 71.79%	11 $0
Q4 2022 Jan 24, 2023	BUY	$40.77 - $53.73 $1,060 - $1,396	26 Added 200.0%	39 $0
Q2 2022 Aug 01, 2022	SELL	$38.13 - $76.93 $2,783 - $5,615	-73 Reduced 84.88%	13 $1,000
Q1 2022 Apr 21, 2022	BUY	$56.06 - $74.11 $4,092 - $5,410	73 Added 561.54%	86 $6,000
Q4 2020 Jan 27, 2021	SELL	$41.16 - $47.47 $452 - $522	-11 Reduced 45.83%	13 $1,000
Q3 2020 Nov 03, 2020	SELL	$43.36 - $53.53 $1,257 - $1,552	-29 Reduced 54.72%	24 $1,000
Q2 2020 Jul 27, 2020	BUY	$46.37 - $57.58 $927 - $1,151	20 Added 60.61%	53 $3,000
Q1 2020 Apr 22, 2020	BUY	$40.22 - $62.0 $1,327 - $2,046	33 New	33 $2,000

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $194M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Lindbrook Capital, LLC with notifications on news.